Lineage Cell Therapeutics
LCTX
#8800
Rank
โ‚น9.39 B
Marketcap
โ‚น42.64
Share price
0.93%
Change (1 day)
-51.60%
Change (1 year)

Lineage Cell Therapeutics (LCTX) Fails to deliver data

Key failure to deliver metrics for Lineage Cell Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lineage Cell Therapeutics (LCTX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lineage Cell Therapeutics (LCTX) - since 2019

Volume in USD (price x number of shares), data since 2019

Lineage Cell Therapeutics (LCTX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚น1.49 M-21.67%
2023โ‚น1.9 M-54.82%
2022โ‚น4.21 M-66.55%
2021โ‚น12.59 M159.36%
2020โ‚น4.85 M399.21%
2019โ‚น0.97 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚น1 Mโ‚น6 M๐Ÿ‡บ๐Ÿ‡ธ USA